(Q80148306)

English

Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone

scientific article published on 12 April 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Fiehn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S Jacki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

B Heilig

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

M Lampe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

G Wiesmüller

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C Richter

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

E Röther

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

E Rochel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

I Gao

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

12 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Rheumatology International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

975-979

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429636%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

High dose intravenous methotrexate for refractory rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation of leflunomide (LEF) to 40 mg once daily in patients with rheumatoid arthritis and insufficient response to standard dose LEF.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with higher dose intravenous methotrexate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current use of glucocorticoids in patients with rheumatoid arthritis in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/17429636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80148306&oldid=2220824086"